Target intelligence / Profile preview

Acellular human dermal matrix (ADM)

Target
ADM
Molecular classification
Extracellular matrix, Biologic scaffold, Biomaterial, Other
01

Overview

Acellular human dermal matrix (ADM) is a decellularized, non-immunogenic scaffold derived from human cadaveric skin, primarily composed of extracellular matrix (ECM) components such as collagen, elastin, and glycosaminoglycans [1, 2]. It is processed to remove all cellular and antigenic materials while preserving the structural and biochemical integrity of the dermal layer [4, 5]. ADM serves as a biological framework that facilitates host cell infiltration, revascularization, and tissue regeneration in various clinical applications, including breast reconstruction, chronic wound management, and hernia repair [2, 10]. By mimicking the native tissue environment, it promotes organized remodeling and reduces the risk of scarring and foreign body response [11, 13]. Although not a molecular drug target in the traditional sense, ADM is a critical therapeutic biomaterial used to support and replace damaged soft tissues [1, 7].

Other names
Human acellular dermal matrixHADMDecellularized dermal matrixAllogenic acellular dermal matrixBiologic scaffoldBiologic matrixDermal allograft
02

Mechanism of action

Acts as a three-dimensional scaffold that mimics the native extracellular matrix (ECM), providing structural support and biochemical cues (such as collagen and elastin) that facilitate host cell infiltration, revascularization, and tissue remodeling, eventually being replaced by host tissue.

03

Biological functions

Tissue regenerationWound healingStructural supportCell migrationAngiogenesisCell proliferationOther
04

Disease associations

Chronic woundsBurnsBreast reconstructionHernia repairPeriodontal defectsSoft tissue defectsOther
05

Safety considerations

InfectionSeromaHematomaNecrosisGraft failureImmunogenicityHigh cost
06

Biomarkers

Wound closure rateGraft take percentageTissue thicknessTissue flexibility

Beyond the preview

Go deeper on Acellular human dermal matrix (ADM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acellular human dermal matrix (ADM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call